港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

603.226

+23.8664.12%

漲家數：33

跌家數：- -

平家數：1

市盈率：- -

高：605.009

開：579.115

低：567.229

收：579.360

成交量：1.24億

成交額：24.03億

市值：3,836.73億

流通市值：3,429.62億

資料載入中...

總覽新聞資訊

科濟藥業－Ｂ(02171)股價上升8%，現價港幣$17.28

阿斯达克财经

《大行》野村：中生製藥(01177.HK)去年純利遠遜預期受一次性因素影響

阿斯达克财经

藥明巨諾－Ｂ(02126)股價上升5.376%，現價港幣$1.96

阿斯达克财经

華領醫藥-B早盤大升逾14% 2025年實現創紀錄盈利

亞盛醫藥－Ｂ(06855)股價上升5.005%，現價港幣$44.9

阿斯达克财经

創新藥概念板塊集體走高石藥集團(01093)漲7.11% 機構指當前醫藥板塊資金面充裕

加科思－Ｂ(01167)股價上升5.038%，現價港幣$6.88

阿斯达克财经

港股異動 | 生物醫藥股普漲，基石藥業-B升逾13%，華領醫藥升逾11%

老虎资讯综合

滬指接近翻紅，醫藥股爆發，算力硬件股繼續調整，恒指震盪走高，新消費概念股反彈，泡泡瑪特漲2%

华尔街见闻

雲頂新耀：BD不會一賣了之，兩款產品將參與醫保談判

華領醫藥(02552)2025年度業績：華堂寧®銷量超400萬盒盈利實現歷史性突破

再鼎醫藥(09688)發布年度業績總收入按年增加15%至4.6億美元各產品管線進展積極

信達生物2025年首次扭虧為盈；周雲曙出任先聲藥業CEO | 醫藥早參

每日经济新闻

恒瑞醫藥創新藥收入佔比近六成 BD重構國際化價值錨點

21世纪经济报道

家族控股特點鮮明親屬企業獲取億元推廣費漢方製藥關聯交易與鉅額派息引關注

交易額最高9475萬美元！英硅智能上市不到3個月，宣佈第4筆國內AI製藥合作

每日经济新闻

歐康維視生物-B(01477)：建議委任莊蓓蓓為獨立非執行董事

歐康維視生物-B(01477)發布年度業績，淨虧損1.59億元按年減少40.8%

康方生物(09926)發布年度業績，收入按年增長43.9%至30.56億元

康諾亞-B(02162)發布年度業績股東應占虧損5.23億元按年擴大1.44%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":603.22595,"timestamp":1774583997788,"preClose":579.3598,"halted":0,"volume":124009071,"delay":0,"changeRate":0.041194,"floatShares":0,"shares":0,"eps":0,"marketStatus":"午間休市","change":23.86615,"latestTime":"03-27 12:00:00","open":579.1151,"high":605.0094,"low":567.22943,"amount":2402981765,"amplitude":0.06521,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774587600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1774575000000,1774584000000],[1774587600000,1774598400000]],"pbRate":5.137827,"peRate":-72.511291,"turnoverRate":0.004522,"increases":33,"decrements":0,"flats":0,"marketCap":383673260096,"floatMarketCap":342961836304},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":605.0094,"amplitude":0.06521,"preClose":579.3598,"low":567.22943,"pbRate":"5.137827","latestPrice":603.22595,"volume":124009071,"delay":0,"open":579.1151,"prevYearClose":556.26263,"prevWeekClose":560.669,"prevMonthClose":553.496,"prevQuarterClose":556.263,"fiveDayClose":560.669,"twentyDayClose":553.496,"sixtyDayClose":561.301,"secType":"PLATE","market":"HK","turnoverRate":0.004522,"peRate":-72.511291,"marketCap":383673260096,"floatMarketCap":342961836304,"timestamp":1774583997788,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":33,"down":0,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622819360","title":"科濟藥業－Ｂ(02171)股價上升8%，現價港幣$17.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2622819360","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622819360?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 10:30","pubTimestamp":1774578600,"startTime":"0","endTime":"0","summary":"[上升股]科济药业－Ｂ(02171) 股价在上午10:30比前收市价上升8%，现股价为港币$17.28。至目前为止，今日最高价为$17.28，而最低价为$15.75。总成交量为344.778万股，总成交金额为港币$5.791千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260327968/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260327968/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02171","BK1161","BK1587","BK1585","BK1574"],"gpt_icon":0},{"id":"2622081608","title":"《大行》野村：中生製藥(01177.HK)去年純利遠遜預期 受一次性因素影響","url":"https://stock-news.laohu8.com/highlight/detail?id=2622081608","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622081608?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 10:23","pubTimestamp":1774578180,"startTime":"0","endTime":"0","summary":"野村发表研究报告指，中国生物制药去年收入按年增10%至318亿人民币，符合管理层双位数增长指引及该行预期，惟低于市场预测的331亿元人民币；纯利按年下跌33%至23亿元人民币，远低于市场预期的49亿元人民币。管理层表示non-HKFRS调整后利润为45亿人民币，按年增长31%。主要的非经常性项目导致差异的原因，是约21亿人民币的资产公允价值变动/减值。展望2026年，野村认为创新药持续快速增长，加上合作收入，应有助公司维持双位数的销售增长。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220728114526454_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220728114526454_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1513281/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1513281/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1515","01177","IE00BZ08YT58.USD","BK1521","01477","BK1574","IE00BZ08YS42.EUR","BK1589","HK0000165453.HKD","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2622816454","title":"藥明巨諾－Ｂ(02126)股價上升5.376%，現價港幣$1.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2622816454","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622816454?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 10:10","pubTimestamp":1774577400,"startTime":"0","endTime":"0","summary":"[上升股]药明巨诺－Ｂ(02126) 股价在上午10:10比前收市价上升5.376%，现股价为港币$1.96。至目前为止，今日最高价为$1.96，而最低价为$1.86。总成交量为16.1万股，总成交金额为港币$30.63万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260327847/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260327847/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1583","BK1574","02126"],"gpt_icon":0},{"id":"2622816348","title":"華領醫藥-B早盤大升逾14% 2025年實現創紀錄盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2622816348","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622816348?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 10:07","pubTimestamp":1774577220,"startTime":"0","endTime":"0","summary":"　　华领医药-B早盘大涨超14%，截至发稿，股价上涨14.15%，现报3.55港元，成交额1761.08万港元。　　华领医药公布2025年度业绩。报告期内，产品销量达401.1万盒，同比增长91%；净销售额达4.929亿元，同比增长93%。　　公司2025年实现创纪录盈利，税前盈利达11.064亿元；现金余额稳健，截至年末达 10.923亿元，为持续运营发展奠定坚实基础；毛利率提升至56.9%，销售开支占比从59.9%优化至33.6%，盈利能力显著增强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-03-27/doc-inhskwcy5418407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1191","02552"],"gpt_icon":0},{"id":"2622816617","title":"亞盛醫藥－Ｂ(06855)股價上升5.005%，現價港幣$44.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2622816617","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622816617?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 10:05","pubTimestamp":1774577100,"startTime":"0","endTime":"0","summary":"[上升股]亚盛医药－Ｂ(06855) 股价在上午10:05比前收市价上升5.005%，现股价为港币$44.9。至目前为止，今日最高价为$44.9，而最低价为$42.26。总成交量为41.56万股，总成交金额为港币$1.812千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260327777/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260327777/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"2622681637","title":"創新藥概念板塊集體走高 石藥集團(01093)漲7.11% 機構指當前醫藥板塊資金面充裕","url":"https://stock-news.laohu8.com/highlight/detail?id=2622681637","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622681637?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 10:04","pubTimestamp":1774577076,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念板块集体走高，石药集团 涨7.11%，云顶新耀涨5.77%，信达生物涨3.72%，科伦博泰生物-B涨2.85%，百济神州涨3.29%，先声药业涨3.22%，复星医药涨2.87%，三生制药涨3.31%。消息面上，东吴证券通过计算“现金及现金等价物/年研发费用”来评估创新药板块的资金面是否充裕。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977459","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","LU0307460666.USD","LU0072913022.USD","01952","02096","LU1226287529.USD","SG9999004220.SGD","BK1574","BK1500","LU1226288170.HKD","BK1521","LU1951186391.HKD","LU0502904849.HKD","159938","LU0314109678.HKD","LU2097828474.EUR","LU2039709279.SGD","HK0000165453.HKD","159992","BK1191","LU1969619763.USD","BK1589","06160","LU0501845795.SGD","IE00BZ08YS42.EUR","LU1008478684.HKD","LU1152091168.USD","LU0067412154.USD","LU0588546209.SGD","BK1583","LU0140636845.USD","LU1251922891.USD","09939","01093","LU1813983027.USD","IE00B031HY20.USD","LU1226288253.USD","LU2097828631.EUR","LU1226287875.USD","IE0008368742.USD","02196","01530","LU1807302812.USD","LU1303224171.USD","LU1226287792.SGD","06978","IE00B5MMRT66.SGD","06990","BK1161","LU0880133367.SGD"],"gpt_icon":0},{"id":"2622816531","title":"加科思－Ｂ(01167)股價上升5.038%，現價港幣$6.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2622816531","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622816531?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 10:00","pubTimestamp":1774576800,"startTime":"0","endTime":"0","summary":"[上升股]加科思－Ｂ(01167) 股价在上午10:00比前收市价上升5.038%，现股价为港币$6.88。至目前为止，今日最高价为$6.88，而最低价为$6.37。总成交量为37.08万股，总成交金额为港币$246.167万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260327720/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260327720/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"1169861203","title":"港股異動 | 生物醫藥股普漲，基石藥業-B升逾13%，華領醫藥升逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169861203","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169861203?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 09:57","pubTimestamp":1774576637,"startTime":"0","endTime":"0","summary":"3月27日，生物医药股普涨，$基石药业-B(02616)$涨超13%，华领医药涨超11%，$开拓药业(09939)$、$来凯医药(02105)$、先瑞达医疗等多股涨超5%","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1161","BK1574","BK4585","02552","BK4581","02616","BK4588"],"gpt_icon":0},{"id":"2622816896","title":"滬指接近翻紅，醫藥股爆發，算力硬件股繼續調整，恒指震盪走高，新消費概念股反彈，泡泡瑪特漲2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622816896","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622816896?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 09:39","pubTimestamp":1774575552,"startTime":"0","endTime":"0","summary":"创新药概念表现活跃，联环药业触及涨停，美诺华6天5板，金凯生科、海创药业、科兴制药、德展健康、万邦德跟涨。早盘军工板块异动拉升，建设工业4天2板，北方长龙、长城军工、捷强装备、内蒙一机、国科军工等冲高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3768539","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3768539","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","SG9999002950.SGD","LU1770036033.HKD","LU2543165471.USD","000905.SH","LU0348767384.USD","LU0588546209.SGD","IE0034224299.USD","LU0611395673.USD","LU0531971595.HKD","LU0164865239.USD","LU0231483743.USD","000688.SH","LU1880383440.USD","510880","LU0359201885.HKD","399001","LU1880383366.USD","LU0039217434.USD","LU1481107354.HKD","MCHmain","512880","SGXZ86797644.SGD","LU0149721374.USD","BK1161","LU0499858602.USD","SGXZ62798434.SGD","LU0823426480.USD","LU0359202008.SGD","09992","512510","LU0345775950.USD","LU0593848301.USD","513600","000300.SH","LU0823426308.USD","BK1574","LU0499858438.USD","000001","LU0348766576.USD","PMRTY","399006","LU0359201612.USD","510300","LU0307460666.USD","LU1023057109.AUD","LU0327786744.USD","SG9999001069.SGD","515890","02833","BK1224","LU0211977185.USD","LU0572944931.SGD","LU0345776255.USD","159967","BK1515","HHImain","LU0164880469.USD","HSI","LU0871576103.HKD"],"gpt_icon":1},{"id":"2622818778","title":"雲頂新耀：BD不會一賣了之，兩款產品將參與醫保談判","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818778","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622818778?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 08:49","pubTimestamp":1774572540,"startTime":"0","endTime":"0","summary":"“对于BD，我们的态度是，不会‘卖青苗’，而是要找到战略上有协同、能力上能互补、财务上稳健的合作方，帮我们一起共同开发，而不是简单地把它卖掉，这是我们的原则。我们不是一卖了之，我们希望看到长远，能够帮助这些有突破性技术的产品，实现它的长远价值，这是我们最在乎的。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603273686333750.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603273686333750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","01952","BK1583"],"gpt_icon":0},{"id":"2622608890","title":"華領醫藥(02552)2025年度業績：華堂寧®銷量超400萬盒 盈利實現歷史性突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2622608890","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622608890?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 08:07","pubTimestamp":1774570071,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华领医药 公布截至2025年12月31日止年度经审核的综合业绩。报告期内，公司核心产品、全球首创糖尿病新药、葡萄糖激酶激活剂华堂宁商业化进程全面提速，研发管线持续丰富，财务表现实现历史性突破，成功迈入盈利新阶段。公司预计将于2026年提交多格列艾汀用于MODY-2患者的IND申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"华领医药(02552)2025年度业绩：华堂宁®销量超400万盒 盈利实现历史性突破","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02552","BK1191","BK1574"],"gpt_icon":0},{"id":"2622570897","title":"再鼎醫藥(09688)發布年度業績 總收入按年增加15%至4.6億美元 各產品管線進展積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2622570897","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622570897?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 07:20","pubTimestamp":1774567240,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药 发布截至2025年12月31日止财政年度全年业绩，产品收入净额增加15%至4.57亿美元，主要是由于鼎优乐的销售增加及纽再乐的销售增加。每股基本及摊薄亏损为0.16美元。于2025年，公司的财务业绩持续强势，总收入较上年增加15%至4.6亿美元，而净亏损则减少32%至1.76亿美元。于2026年，公司预计收入将持续增长，主要得益于现有商业化产品以及近期获批并预计于今年内上市的产品或新适应证。公司的各产品管线方面亦继续取得进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"再鼎医药(09688)发布年度业绩 总收入同比增加15%至4.6亿美元 各产品管线进展积极","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","BK4531","BK4526","BK1574","ZLAB","BK4548","BK1588","BK4139","LU2488822045.USD","09688","BK1161"],"gpt_icon":1},{"id":"2622289783","title":"信達生物2025年首次扭虧為盈；周雲曙出任先聲藥業CEO | 醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2622289783","media":"每日经济新闻","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622289783?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 07:00","pubTimestamp":1774566006,"startTime":"0","endTime":"0","summary":"丨2026年3月27日星期五丨NO.1京东健康宿迁天宁股权结构调整3月26日，京东健康宣布，为提高行政效率，李娅云于2026年3月26日订立股权转让协议，据此李娅云同意将其在宿迁天宁持有的30%股权转让予隋婷婷。由于一名登记股东变更，宿迁天宁、外商独资企业及新登记股东订立新合同安排，现有合同安排同时终止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603273686096042.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603273686096042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1146622755.USD","BK0012","LU1997245177.USD","BK0239","LU2580892789.USD","BK1191","LU1997245094.SGD","09939","LU2488822045.USD","LU2097828474.EUR","LU2289578879.USD","BK0196","LU2242644610.SGD","BK0060","LU1255011170.USD","LU0405327148.USD","LU1064131003.USD","LU0455707207.USD","BK0188","LU2097828631.EUR","BK1515","LU1580142542.USD","LU2097828714.EUR","LU2148510915.USD","LU1781817850.SGD","01801","BK0028","159938","LU0502904849.HKD","LU2580892862.HKD","BK0183","LU2097828805.USD","02096","LU2328871848.SGD","LU1997244956.HKD","LU1655091616.SGD","BK1583","LU0405327494.USD","600276","BK1161","LU1064130708.USD","BK1574","LU1328615791.USD","LU2097828557.USD","HK0000165453.HKD","LU1820825898.SGD","BK1589","LU1969619763.USD","LU2495084118.USD"],"gpt_icon":0},{"id":"2622789788","title":"恒瑞醫藥創新藥收入佔比近六成 BD重構國際化價值錨點","url":"https://stock-news.laohu8.com/highlight/detail?id=2622789788","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622789788?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 07:00","pubTimestamp":1774566000,"startTime":"0","endTime":"0","summary":"3月25日，恒瑞医药（600276.SH，01276.HK）发布2025年年度报告。财报显示，全年实现营业收入316.29亿元，同比增长13.02%；归属于上市公司股东的净利润77.11亿元，同比增长21.69%；归属于上市公司股东的扣除非经常性损益的净利润74.13亿元，同比增长20.00%。这一增速显著超出行业平均水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603273686095212.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603273686095212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2097828557.USD","LU2543165471.USD","LU1820825898.SGD","BK0183","BK1161","LU1023057109.AUD","LU0359201885.HKD","LU1997244956.HKD","LU1997245177.USD","01276","LU2495084118.USD","BK0239","LU1655091616.SGD","LU1781817850.SGD","LU2148510915.USD","LU0359202008.SGD","LU2097828631.EUR","LU2097828805.USD","BK1574","LU2580892862.HKD","LU1997245094.SGD","06978","BK0012","LU1255011170.USD","159992","LU0405327494.USD","LU2488822045.USD","LU1064131003.USD","BK1191","LU1580142542.USD","BK0188","BK0028","LU0405327148.USD","LU1328615791.USD","LU2097828714.EUR","LU1064130708.USD","BK0060","LU2580892789.USD","LU2328871848.SGD","LU1969619763.USD","LU1146622755.USD","LU0359201612.USD","LU2289578879.USD","LU2097828474.EUR","BK0196","600276"],"gpt_icon":0},{"id":"2622976458","title":"家族控股特點鮮明 親屬企業獲取億元推廣費 漢方製藥關聯交易與鉅額派息引關注","url":"https://stock-news.laohu8.com/highlight/detail?id=2622976458","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622976458?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 03:48","pubTimestamp":1774554480,"startTime":"0","endTime":"0","summary":"　　作为一家赴港上市中药企业，山东汉方制药股份有限公司的招股书显现鲜明的家族企业特质。招股书显示，目前汉方制药由秦文基、秦银基兄弟100%控股，管理层存在多位家族成员，董事长外甥控制的企业曾作为关联方长期获取巨额推广费，且在上市前进行了数额可观的现金分红。这些信息勾勒出公司的经营治理架构，引发了市场对其决策独立性、关联交易公允性及长期发展可持续性的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-03-27/doc-inhskfhc9844570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","01477","BK4585","BK4588","BK1191","VIG"],"gpt_icon":0},{"id":"2622867591","title":"交易額最高9475萬美元！英硅智能上市不到3個月，宣佈第4筆國內AI製藥合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2622867591","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622867591?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 00:31","pubTimestamp":1774542710,"startTime":"0","endTime":"0","summary":"中国AI（人工智能）制药领域迎来一笔新合作。3月26日，英硅智能（HK03696，股价50.30港元，市值287.92亿港元）公告称，在过去一年良好的合作关系基础上，公司与元羿生物已达成一项扩展的AI驱动研发合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603273686033797.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603273686033797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","01477","AGIX","AIPO","BK1574","CHAT"],"gpt_icon":0},{"id":"2622786408","title":"歐康維視生物-B(01477)：建議委任莊蓓蓓為獨立非執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2622786408","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622786408?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 23:47","pubTimestamp":1774540074,"startTime":"0","endTime":"0","summary":"智通财经APP讯，欧康维视生物-B 发布公告，胡定旭先生于服务超过五年后，将根据公司的公司章程细则于公司应届股东周年大会上退任。胡先生已告知董事会，彼决定不于股东周年大会上膺选连任，以投入更多时间处理其他事务。鉴于胡先生即将退任，于2026年3月26日，董事会议决将于股东周年大会上建议委任庄蓓蓓女士为独立非执行董事，以填补胡先生退任后的董事会空缺，自股东周年大会结束起生效，惟须待股东批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","BK1574","BK1191"],"gpt_icon":0},{"id":"2622486429","title":"歐康維視生物-B(01477)發布年度業績，淨虧損1.59億元 按年減少40.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622486429","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622486429?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 23:45","pubTimestamp":1774539902,"startTime":"0","endTime":"0","summary":"智通财经APP讯，欧康维视生物-B 发布截至2025年12月31日止年度业绩，该集团取得收益8.04亿元，同比增加92.75%;年内亏损1.59亿元，同比减少40.8%;每股亏损0.2元。公司进一步拓展院内市场，主要产品销量保持稳定增长。博优景 获NMPA批准上市，用于治疗成人新生血管(湿性)年龄相关性黄斑变性及糖尿病黄斑水肿，这标志着公司在眼底疾病领域又一重要产品的诞生。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01477","BK1191"],"gpt_icon":0},{"id":"2622610318","title":"康方生物(09926)發布年度業績，收入按年增長43.9%至30.56億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622610318","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622610318?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 23:14","pubTimestamp":1774538074,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康方生物 发布截至2025年12月31日止年度业绩，该集团取得收入人民币30.56亿元，同比增加43.9%;毛利24.04亿元，同比增加31.01%;研发开支15.75亿元，同比增加32.61%;年内亏损11.41亿元，每股亏损1.23元。作为全球领先的双特异性抗体公司，康方生物2025年继续在世界一流的研发方面取得显著投资进展，同时较2024年缩小了Non-IFRS年内EBITDA，从而提升了财务表现。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康方生物(09926)发布年度业绩，收入同比增长43.9%至30.56亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348767384.USD","LU2399975544.HKD","LU1961090484.USD","LU1794554557.SGD","LU0417516738.SGD","BK1161","LU0348783233.USD","LU0348735423.USD","IE00B543WZ88.USD","LU0540923850.HKD","LU0348825331.USD","LU1720050803.USD","IE00B5MMRT66.SGD","BK1574","LU0561508036.HKD","LU0348784397.USD","LU0417516571.SGD","LU0348827113.USD","IE00BPRC5H50.USD","LU2476274308.USD","LU2778985437.USD","LU2476274720.SGD","LU0417516902.SGD","LU0634319403.HKD","09926","LU2488822045.USD","LU0348766576.USD"],"gpt_icon":1},{"id":"2622868626","title":"康諾亞-B(02162)發布年度業績 股東應占虧損5.23億元 按年擴大1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622868626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622868626?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 20:58","pubTimestamp":1774529912,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康诺亚-B(02162)发布截至2025年12月31日止年度业绩，该集团期内取得收入7.16亿元人民币，同比增加67%;母公司拥有人应占亏损5.23亿元，同比扩大1.44%;每股基本亏损1.91元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1587","BK1574","BK1583","02162"],"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":1,"totalSize":310,"code":"91000000","status":"200"}]}}